GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

IRadimed IRMD · USD

Health Care · US listing · 🇺🇸 United States

Compare

86.94

+0.73%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$83.8m

FY2016FY2025

Net income

$22.5m

FY2016FY2025

Free cash flow

$17.2m

FY2016FY2025

Shareholders' equity

$94.6m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$83.8m$73.2m$65.6m$53.3m$41.8m$31.7m$38.5m$30.4m$23.1m$32.5m
Gross profit$64.3m$56.3m$50.2m$41.3m$32.0m$23.6m$29.7m$23.2m$17.5m$26.3m
Research and development$3.0m$2.8m$2.9m$2.3m$1.9m$1.9m$1.4m$1.5m$1.7m$1.3m
Operating income$26.1m$22.0m$20.0m$15.6m$9.8m−$756,091$8.6m$6.0m$1.3m$10.9m
Net income$22.5m$19.2m$17.2m$12.8m$9.3m$1.4m$9.6m$6.3m$499,764$7.2m
Diluted earnings per share1.751.501.351.020.740.110.780.520.040.62

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$108.8m$98.3m$92.2m$85.5m$82.9m$71.1m$66.7m$48.4m$39.0m$37.2m
Cash and short-term investments$51.2m$52.2m$49.8m$58.0m$62.5m$52.0m$46.3m$34.4m$26.3m$25.7m
Total liabilities$14.2m$11.5m$20.7m$11.8m$10.7m$9.7m$11.2m$6.5m$6.1m$5.3m
Shareholders' equity$94.6m$86.8m$71.4m$73.7m$72.2m$61.4m$55.5m$41.9m$32.9m$31.9m
Shares outstanding13m13m13m13m13m13m12m12m12m12m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations$24.9m$25.6m$13.5m$10.0m$11.3m$5.8m$10.2m$7.4m$3.4m$9.4m
Capital spending−$7.8m−$8.0m−$8.0m−$1.9m−$741,759−$636,746−$485,812−$264,665−$824,763−$1.5m
Free cash flow$17.2m$17.6m$5.5m$8.2m$10.5m$5.2m$9.7m$7.1m$2.6m$7.9m
Dividends paid−$15.0m−$13.7m−$13.2m−$12.6m−$12.6m−$12.6m−$12.6m———

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$20.5m$22.0m$22.7m$21.2m$20.4m$19.5m$19.4m$18.3m
Gross profit$15.2m$16.8m$17.0m$16.5m$16.0m$14.8m$14.8m$14.2m
Operating income$6.4m$7.2m$7.1m$6.8m$6.8m$5.4m$5.8m$5.8m
Net income$5.2m$5.8m$6.4m$5.6m$5.8m$4.7m$5.1m$5.0m
Diluted earnings per share0.410.450.500.430.450.360.400.39
Cash from operations$5.0m$8.0m$5.0m$6.0m$7.0m$4.0m$5.0m$9.0m
Capital spending———−$1.0m−$2.0m−$3.0m−$3.0m−$4.0m
Free cash flow———$5.0m$5.0m$1.0m$2.0m$5.0m
Total assets$115.0m$114.4m$108.8m$114.7m$106.4m$101.7m$98.3m$94.2m
Cash and short-term investments$59.1m$56.4m$51.2m$56.5m$53.0m$50.3m$52.2m$51.7m
Debt—————$59,221$153,264$261,244
Shareholders' equity$101.7m$98.5m$94.6m$98.4m$94.3m$90.1m$86.8m$83.4m

Financial ratios

Data as of 4 Nov 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Gross margin76.7%76.9%76.5%77.4%76.6%74.3%—
Operating margin33.8%33.1%30.6%29.3%23.5%-2.4%—
Net margin26.8%26.3%26.2%24.1%22.3%4.3%—
Return on equity23.8%22.2%24.1%17.4%12.9%2.2%—
Return on assets20.7%19.6%18.7%15.0%11.3%1.9%—
Free cash flow yield3.1%3.2%2.1%1.2%1.2%0.6%—
Revenue growth14.4%11.7%23.0%27.5%31.8%-17.7%—
Earnings growth16.9%11.9%34.0%37.6%581.2%-85.8%—
Current ratio7.98x8.84x4.65x9.06x11.18x12.96x—
Debt to equity—0.00x0.01x0.00x0.00x0.00x0.00x
Equity ratio87.0%88.3%77.5%86.2%87.1%86.4%—
Interest coverage———26.86x528.69x-5.43x21.84x
R&D as a share of sales3.5%3.9%4.4%4.3%4.6%6.0%—
Buybacks as a share of market value-0.7%-0.3%-0.9%0.0%-0.9%-1.4%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue16.3%21.5%10.2%
Operating income18.7%—8.5%
Net income20.6%75.0%11.6%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin76.8%76.9%76.6%77.2%
Operating margin30.6%30.4%26.6%26.0%
Net margin26.6%26.0%23.6%22.5%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings55.736.535.227.962.6208.430.047.4357.418.0
Price to sales14.99.69.26.714.09.07.59.87.74.0

Market value over time

30 Nov 2016 to 3 Nov 2026, in USD

$131.1m$1.04bn

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return84%14%56%-34%90%-7%7%77%3%-22%

Dividends and splits

Per share, in the currency the company pays

Paid for 4 years. Last went ex-dividend on 13 Nov 2026.

FY2026FY2025FY2024FY2023FY2022
Paid in the year0.801.180.451.531.00

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.